Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in hospitalized COVID-19 pneumonia
NCT04341675Phase 2Completed
- Sponsor
- University of Cincinnati
- Start
- Apr 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in COVID-19 pneumonia, sponsored by University of Cincinnati. Started Apr 2020; status: completed.
02
Drugs
sirolimus
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04341675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04341675.